Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries
NCT05913180Phase 2Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Sep 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in catheter-associated urinary tract infection (CAUTI) comparing Vitamin C with Placebo (2 arms). Primary endpoint: Incidence of Urinary Tract Infection at 30 days. Started Sep 2023; status: completed.
02
Drugs
ascorbic acid
03
Conditions
catheter-associated urinary tract infection (CAUTI)
Beyond the preview
Go deeper on NCT05913180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05913180.